Latest News
Pharming launches Joenja in Japan for APDS patients aged four and above
...
Aurisco Pharmaceutical reports successful US FDA inspection
13 August 2026 - Oligonucleotide and peptide (TIDES) manufacturer Aurisco Pharmaceutical Co Ltd (SSE:605116) announced on Wednesday that its site in Yangzhou, China has passed US FDA inspection as the first generic oligonucleotide API manufacturer in...
BioCare climbs 1,145 places on Inc. 5000 list
13 August 2026 - BioCare, a specialty pharmaceutical distributor comprised of BioCareSD and LogiCare3PL, announced on Wednesday that Inc. Magazine has named the company in the 2026 Inc. 5000, its annual list recognising the fastest-growing private co...
PTC to acquire BLA-stage ST-920 Fabry disease programme
13 August 2026 - US biopharmaceutical company PTC Therapeutics Inc (NASDAQ:PTCT) announced on Wednesday that it was selected as the winning bidder to acquire ST-920, a BLA-stage, one-time administered AAV gene therapy for Fabry disease, from Sangamo ...
Quest Diagnostics declares quarterly dividend of of USD0.86 per share
13 August 2026 - Quest Diagnostics (NYSE:DGX), a provider of diagnostic information services, announced on Wednesday that its board of directors declared a quarterly cash dividend of USD0.86 per share.This amount is unchanged from the previous quarte...